Real-time quantitation of bcr-abl transcripts in haematological malignancies

Area of Science:

• Hematology
• Molecular Biology
• Oncology

Background:

• The t(9;22) translocation, also known as the Philadelphia chromosome, is a hallmark genetic abnormality in several hematological malignancies.
• Accurate detection and monitoring of this translocation are crucial for diagnosis, prognosis, and treatment management.

Purpose of the Study:

• To evaluate an automated real-time quantitative PCR assay for detecting t(9;22)-positive cells in hematological malignancies.
• To assess the assay's utility in diagnosis and patient follow-up.

Main Methods:

• Application of an automated real-time quantitative PCR assay using a double-labeled fluorogenic probe.
• Quantification of chimeric bcr-abl transcripts relative to abl transcripts.
• Comparison of results with conventional nested RT-PCR and cytogenetics.

Main Results:

• The assay demonstrated high reproducibility for t(9;22)-positive K562 RNA.
• Detection limits included ten copies of bcr-abl DNA and one positive cell in 10^4.
• Real-time quantitative RT-PCR values showed good correlation with conventional methods.
• The assay identified early relapse or blastic transformation in some cases through kinetic analysis.

Conclusions:

• Automated real-time quantitative PCR is a sensitive and reproducible method for detecting the t(9;22) translocation.
• This technique is suitable for the diagnosis and follow-up of patients with t(9;22)-positive hematological malignancies.
• Real-time quantitative RT-PCR offers valuable insights into disease kinetics, aiding in early relapse detection.